News
-
-
COMMUNIQUÉ DE PRESSE
Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD)
Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD). Vi Partners leads the financing round alongside existing investors Schroders Capital, Zürcher Kantonalbank, and Verve Ventures -
-
-
COMMUNIQUÉ DE PRESSE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Communiqué de l'entreprise sur le nombre total de droits de vote et d'actions en circulation composant son capital au 30.09.2024. Informations conformes aux exigences de l'AMF -
-
COMMUNIQUÉ DE PRESSE
centrotherm with satisfactory business performance in the first half of 2024; confirmation of full-year forecast
centrotherm international AG reports satisfactory business performance in the first half of 2024, with orders from semiconductor and photovoltaic industries. Full-year forecast confirmed -
COMMUNIQUÉ DE PRESSE
IBU-tec advanced materials AG Battery Materials Breakthrough! Multimillion Euro LFP Order for Global Automotive Group Secured
IBU-tec advanced materials AG secures multimillion Euro LFP order for global automotive group, impacting 2024 fiscal year positively. Expansion of cooperation planned -
-
